Nanomedicine-based technologies and novel biomarkers for the diagnosis and treatment of Alzheimer’s disease: from current to future challengesAmanda Cano, Merçé Boada, Elena Sánchez‐López et al.|Journal of Nanobiotechnology|2021Cited by 122
Nanomedicine against Aβ Aggregation by β–Sheet Breaker Peptide Delivery: In Vitro EvidenceFrancesca Pederzoli, Andreas M. Grabrucker, Giovanni Tosi et al.|Pharmaceutics|2019Cited by 30